This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Latest news
Stay informed on our major announcements through our media releases and other updates.
-
-
-
News articles
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions. -
-
Safety updates
Refer to our articles for health professionals about health products and emerging safety issues. -
Health product safety alerts and market actions
See the latest alerts for consumers and health professionals about safety and quality issues with health products.
-
Safety alerts
Refer to the latest safety alerts for medicines or medical devices with possible risks. -
Events and consultations
Have your say on therapeutic goods regulation by participating in our public consultations or browse closed consultations. We also deliver a range of webinars, workshops and meetings on areas of interest for industry, consumers, and health professionals.
-
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals. -
Events
Search our upcoming and past events including webinars, committee meetings, presentations, and workshops.
Our subscription services
Stay connected and sign up to our RSS news feeds and email subscription services to receive real-time updates on our latest news, product shortage alerts, and media releases as we publish them, or subscribe to monthly updates.
-
Email subscriptions
We offer several email subscription options to keep you up to date with news and alerts. -
RSS feeds
RSS feeds (Really Simple Syndication feed) for immediate notifications of updates to the TGA website.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
Updates to the Prescribing Medicines in Pregnancy database - October 2026
News articlesThe Prescription Medicines in Pregnancy database has been updated to include new entries and amend some existing entries. -
Therapeutic Goods (Technical Master File and Type II Plasma Master File - Application Form) Approval 2026
Regulatory decision noticesThis instrument is made under subclause 2(3)(a) of Schedule 5A to the Therapeutic Goods Regulations 1990. -
Outcome of digital scribe review
News articlesOutcomes of our review of digital scribes supplied in Australia.
Latest publications
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - ACCS and Joint ACMS-ACCS meetings - March 2025
-
Corporate reportsOutcomes of the review of digital scribes supplied in Australia.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 30 July 2026
Latest consultations
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking public comment on proposed changes to the Therapeutic Goods (Permissible Ingredients) Determination relating to listed medicines containing vitamin B6, namely pyridoxine hydrochloride, pyridoxal 5-phosphate and pyridoxal 5-phosphate monohydrate.
-
ConsultationHave your say about the content and level of detection for ethylene oxide, propylene oxide and epichlorohydrin in end use products.
-
ConsultationHave your say about proposals to amend the Poisons Standard in relation to 4-methylbenzylidene camphor (4-MBC). These will be considered at the next meeting of the joint meeting of Advisory Committee on Medicines Scheduling (ACMS) and Advisory Committee on Chemicals Scheduling (ACCS).